Cyclophosphamide Treatment Options in United Kingdom

A collection of 244 research studies where Cyclophosphamide is the interventional treatment. These studies are located in the United Kingdom . Cyclophosphamide is used for conditions such as Breast Cancer, Lymphoma and Leukemia.

Home

United Kingdom

All Treatments

Cyclophosphamide

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

NCT06911502

Recruiting

The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/21/2025

Locations: Local Institution - 0225, Birmingham, Alabama +153 locations

Local Institution - 0225, Birmingham, Alabama

Local Institution - 0014, Mobile, Alabama

Alaska Oncology and Hematology, Anchorage, Alaska

Local Institution - 0215, Little Rock, Arkansas

Local Institution - 0072, Duarte, California

Local Institution - 0119, San Francisco, California

Local Institution - 0008, Jacksonville, Florida

Local Institution - 0214, Tampa, Florida

Local Institution - 0217, Tampa, Florida

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Marietta, Georgia

Local Institution - 0245, Newnan, Georgia

Local Institution - 0240, Arlington Heights, Illinois

Local Institution - 0253, Iowa City, Iowa

Local Institution - 0243, Waukee, Iowa

Local Institution - 0216, Westwood, Kansas

Local Institution - 0218, Lexington, Kentucky

Local Institution - 0023, Baltimore, Maryland

Greater Baltimore Medical Center, Towson, Maryland

Local Institution - 0145, Boston, Massachusetts

Local Institution - 0244, Boston, Massachusetts

Local Institution - 0247, Boston, Massachusetts

Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi

Local Institution - 0144, Providence, Rhode Island

Local Institution - 0237, Austin, Texas

Local Institution - 0212, Fort Worth, Texas

Local Institution - 0230, San Antonio, Texas

Local Institution - 0236, Tyler, Texas

Local Institution - 0238, Fairfax, Virginia

Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia

Local Institution - 0146, Roanoke, Virginia

Local Institution - 0143, Vancouver, Washington

Local Institution - 0134, Westmead, New South Wales

Local Institution - 0132, Adelaide, South Australia

Local Institution - 0131, Hobart, Tasmania

Local Institution - 0128, Heidelberg, Victoria

Local Institution - 0198, Malvern, Victoria

Local Institution - 0127, Perth, Western Australia

Local Institution - 0224, Perth, Western Australia

Local Institution - 0159, Vitoria, Espírito Santo

Local Institution - 0088, Niterói, Rio De Janeiro

Local Institution - 0087, Porto Alegre, Rio Grande Do Sul

Local Institution - 0079, Sao Paulo, São Paulo

Local Institution - 0089, Rio de Janeiro, Not set

Local Institution - 0066, São Paulo, Not set

Local Institution - 0092, São Paulo, Not set

Local Institution - 0200, Victoria, British Columbia

Princess Margaret Cancer Centre, Toronto, Ontario

Local Institution - 0250, Québec, Quebec

Local Institution - 0192, Sherbrooke, Quebec

Local Institution - 0226, Sherbrooke, Quebec

Local Institution - 0154, Santiago, Región Metropolitana De Santiago

Local Institution - 0155, Santiago, Región Metropolitana De Santiago

Local Institution - 0153, Santiago, Región Metropolitana De Santiago

Local Institution - 0246, Beijing, Beijing

Local Institution - 0171, Beijing, Beijing

Local Institution - 0172, Fuzhou Fujian, Fujian

Local Institution - 0173, Guangzhou, Guangdong

Local Institution - 0241, Harbin, Heilongjiang

Local Institution - 0176, Wuhan, Hubei

Local Institution - 0175, Changsha, Hunan

Local Institution - 0235, Hohhot, Inner Mongolia

Local Institution - 0233, Suzhou, Jiangsu

Local Institution - 0178, Nanchang, Jiangxi

Local Institution - 0239, Changchun, Jilin

Local Institution - 0177, Changchun, Jilin

Local Institution - 0179, Shenyang, Liaoning

Local Institution - 0242, Shenyang, Liaoning

Local Institution - 0180, Jinan, Shandong

Local Institution - 0181, Shanghai, Shanghai

Local Institution - 0249, Shanghai, Shanghai

Local Institution - 0234, Sichuan, Sichuan

Local Institution - 0182, Tianjin, Tianjin

Local Institution - 0227, Tianjin, Tianjin

Local Institution - 0248, Kunming, Yunnan

Local Institution - 0184, Hangzhou, Zhejiang

Local Institution - 0174, Zhengzhou, Not set

Local Institution - 0151, Oulu, Pohjois-Pohjanmaa

Local Institution - 0152, Turku, Varsinais-Suomi

Local Institution - 0150, Helsinki, Not set

Local Institution - 0100, Pessac, Aquitaine

Local Institution - 0044, Saint-Cloud, Hauts-de-Seine

Local Institution - 0047, Montpellier, Languedoc-Roussillon

Local Institution - 0120, Nantes, Loire-Atlantique

Local Institution - 0048, Lille, Nord

Local Institution - 0042, Pierre-Bénite, Rhône

Local Institution - 0191, Paris, Not set

Local Institution - 0121, Toulouse, Not set

Local Institution - 0163, Ulm, Baden-Württemberg

Local Institution - 0161, Augsburg, Bayern

Local Institution - 0220, Göttingen, Niedersachsen

Local Institution - 0166, Dortmund, Nordrhein-Westfalen

Local Institution - 0193, Düsseldorf, Nordrhein-Westfalen

Local Institution - 0231, Münster, Nordrhein-Westfalen

Local Institution - 0232, Münster, Nordrhein-Westfalen

Local Institution - 0164, Homburg, Saarland

Local Institution - 0165, Chemnitz, Sachsen

Local Institution - 0222, Erfurt, Thüringen

Local Institution - 0167, Jena, Thüringen

Local Institution - 0187, Dresden, Not set

Local Institution - 0162, München, Not set

Local Institution - 0221, Wuerzburg, Not set

Local Institution - 0109, Athens, Attikí

Local Institution - 0107, Αthens, Attikí

Local Institution - 0110, Thessaloniki, Thessaloníki

Local Institution - 0197, Thessaloniki, Thessaloníki

Local Institution - 0111, Alexandroupolis, Not set

Local Institution - 0108, Ioannina, Ípeiros

Local Institution - 0142, New Delhi, Delhi

Local Institution - 0139, Bengaluru, Karnataka

Local Institution - 0141, Mumbai, Maharashtra

Local Institution - 0140, Hyderabad, Telangana

Local Institution - 0138, Hyderabad, Telangana

Local Institution - 0104, Bologna, Emilia-Romagna

Local Institution - 0101, Meldola, Emilia-Romagna

Local Institution - 0103, Rozzano, Milano

Local Institution - 0106, Pisa, Toscana

Local Institution - 0102, Alessandria, Not set

Local Institution - 0105, Napoli, Not set

Local Institution - 0157, Torino, Not set

Aiiku Hospital, Sapporo, Hokkaido

Japanease Red Cross Society Himeji Hospital, Himeji, Hyogo

Local Institution - 0201, Morioka, Iwate

University of Yamanashi Hospital, Chuo, Yamanashi

Local Institution - 0059, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0060, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0061, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0058, Seoul, Not set

Local Institution - 0050, Amsterdam, Noord-Holland

Local Institution - 0046, Groningen, Not set

Local Institution - 0053, Utrecht, Not set

Local Institution - 0188, Warszawa, Mazowieckie

Local Institution - 0186, Kraków, Małopolskie

Local Institution - 0190, Gdynia, Pomorskie

Local Institution - 0185, Skórzewo, Wielkopolskie

Local Institution - 0189, Łódź, Łódzkie

Local Institution - 0099, Dammam, Ash Sharqīyah

Local Institution - 0054, Riyadh, Not set

Local Institution - 0052, Riyadh, Not set

Local Institution - 0158, Sabadell, Barcelona [Barcelona]

Local Institution - 0122, Santander, Cantabria

Local Institution - 0124, Madrid, Madrid, Comunidad De

Local Institution - 0125, Valencia, Valenciana, Comunitat

Local Institution - 0126, Granada, Not set

Local Institution - 0123, Madrid, Not set

Local Institution - 0195, Istanbul- Fatih, İstanbul

Local Institution - 0194, Ankara, Not set

Local Institution - 0196, Antalya, Not set

Local Institution - 0223, Mersin, Not set

Local Institution - 0251, Abu Dhabi, Abū Z̧aby

Local Institution - 0252, Abu Dhabi, Abū Z̧aby

Norfolk and Norwich University Hospitals NHS Foundation Trust, Cringleford, England

Kent and Canterbury Hospital, Canterbury, Kent

Local Institution - 0213, London, London, City Of

Local Institution - 0149, Manchester, Not set

Conditions: Follicular Lymphoma

Learn More ›

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

NCT05999994

Recruiting

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under this master protocol define drug/disease-specific research goals and activities to test them. New studies will be added as new drugs emerge against different cancers. Participation in the trial will depend on how long the benefit lasts.

Gender:

ALL

Ages:

Between 1 year and 39 years

Trial Updated:

08/21/2025

Locations: Childrens Hospital of Alabama, Birmingham, Alabama +71 locations

Childrens Hospital of Alabama, Birmingham, Alabama

Phoenix Children's Hospital, Phoenix, Arizona

Childrens Hospital of Los Angeles, Los Angeles, California

UCLA Medical Center, Los Angeles, California

Children's Hospital of Orange County, Orange, California

Children's Hospital of Colorado, Denver, Colorado

Children's National Medical Center, Washington, District of Columbia

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

Mayo Clinic in Florida, Jacksonville, Florida

Children's Healthcare of Atlanta, Inc. at Egleston, Atlanta, Georgia

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Dana-Farber Cancer Institute, Boston, Massachusetts

C.S. Mott Children's Hospital, Ann Arbor, Michigan

University of Minnesota Hospital, Minneapolis, Minnesota

Children's Mercy Hospital, Kansas City, Missouri

Washington University Medical School, Saint Louis, Missouri

Memorial Sloan Kettering Cancer Center, New York, New York

Nationwide Children's Hosp, Columbus, Ohio

Oregon Health and Science University, Portland, Oregon

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Lifespan Cancer Institute, Providence, Rhode Island

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Cook Children's Hospital, Fort Worth, Texas

Texas Childrens Hospital, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Seattle Children's Hospital Research Foundation, Seattle, Washington

Medical College of Wisconsin, Milwaukee, Wisconsin

Chris O'Brien Lifehouse, Camperdown, Not set

Peter MacCallum Cancer Centre, Melbourne, Not set

Royal Children's Hospital, Melbourne, Not set

The Sydney Children's Hospitals Network, Westmead, Not set

UCL- Saint Luc, Bruxelles, Not set

Universitair Ziekenhuis Gent, Gent, Not set

Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Not set

Centre Leon Berard, Lyon, Not set

Institut Curie, Paris, Not set

Universitaetsklinikum Essen, Essen, Not set

Universitaetsklinikum Freiburg, Freiburg, Not set

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set

IRCCS Istituto Ortopedico Rizzoli, Bologna, Not set

Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Not set

Istituto Nazionale dei Tumori, Milano, Not set

Azienda Ospedaliera Di Padova, Padova, Not set

Ospedale Bambino Gesu, Roma, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Not set

Istituto Clinico Humanitas, Rozzano, Not set

National Cancer Center Hospital, Chuo-ku, Not set

Kyushu University Hospital, Fukuoka, Not set

Hyogo Prefectural Kobe Children's Hospital, Kobe, Not set

Leids Universitair Medisch Centrum, Leiden, Not set

Prinses Maxima Centrum, Utrecht, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Sant Joan de Déu, Esplugues de Llobregat, Not set

Hospital Universitario de Canarias, La Laguna, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Hospital Infantil Universitario Niño Jesús, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

University College Hospital - London, London, Not set

Royal Marsden Hospital, London, Not set

Royal Manchester Children's Hospital, Manchester, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Neoplasms, Child, Adolescent

Learn More ›

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

NCT05605899

Recruiting

The goal of this clinical study is to compare the study drug, axicabtagene ciloleucel, versus standard of care (SOC) in first-line therapy in participants with high-risk large B-cell lymphoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/20/2025

Locations: University of Alabama Hospital, Birmingham, Alabama +89 locations

University of Alabama Hospital, Birmingham, Alabama

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic, Phoenix, Arizona

UC San Diego Moores Cancer Center, La Jolla, California

University of California Los Angeles (UCLA), Los Angeles, California

Stanford Cancer Institute, Palo Alto, California

Colorado Blood Cancer Institute, Denver, Colorado

Moffitt Cancer Center, Tampa, Florida

Georgia Cancer Center at Augusta University, Augusta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

University of Iowa, Iowa City, Iowa

The University of Kansas Hospital, Westwood, Kansas

Norton Cancer Institute, St. Matthews Campus, Shelbyville, Kentucky

Ochsner Clinic Foundation, New Orleans, Louisiana

University of MD Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester, Minnesota

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Montefiore Medical Center, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

Weill Cornell Medical College - NewYork Presbyterian Hospital, New York, New York

Columbia University Medical Center, New York, New York

University of Rochester Medical Center, Rochester, New York

Novant Health Cancer Institute- Hematology, Charlotte, North Carolina

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Prisma Health Cancer Institute, Greenville, South Carolina

Avera Cancer Institute, Sioux Falls, South Dakota

Tennessee Oncology, PLLC, Nashville, Tennessee

Henry-Joyce Cancer Center, Nashville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

The University of Texas, MD Anderson Cancer Center, Houston, Texas

Intermountain LDS Hospital/Blood and Marrow Transplant/ Acute Leukemia Program, Salt Lake City, Utah

Virginia Commonwealth University, Richmond, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

Royal Prince Alfred Hospital, Camperdown, New South Wales

Royal Brisbane and Women's Hospital, South Brisbane, Queensland

Peter MacCallum Cancer Center, Melbourne, Victoria

Medizinische Universität Innsbruck, Innsbruck, Not set

Zuniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU, Salzburg, Not set

Universitätsklinikum St. Pölten, St. Poelten, Not set

Medizinische Universität Wien (AKH Wien, Medical University Vienna and General Hospital Vienna), Vienna, Not set

Jewish General Hospital, Montreal, Not set

The Ottowa Hospital- General Campus, Ottawa, Not set

Princess Margaret Cancer Centre, Toronto, Not set

CHU Bordeaux-Hopital Haut-Leveque, Bordeaux, Not set

Centre Leon Berard, Cedex Lyon 08, Not set

CHU Dijon, Dijon, Not set

Hopital Claude Huriez CHU Lille, Service Maladies du sang, Lille cedex, Not set

Hopital Saint Eloi, Montpellier CEDEX 05, Not set

Centre Hospitalier Universitaire de Nice, Nice, Not set

Hopital Henri MONDOR, APHP, Paris, Not set

CHU Pontchaillou, Rennes CEDEX, Not set

Centre Hospitalier Universitaire(CHU) de Toulouse, Toulouse, Not set

Helios Klinikum Berlin-Buch, Berlin, Not set

Charite Universitaetsmedizin Berlin, Berlin, Not set

Universitätsklinikum bonn, medizinische klinik III, Bonn, Not set

Uniklinikum Duesseldorf, Klinik fuer Haematologie, Onkologie und klinische Immunologie, Duesseldorf, Not set

Universitätsklinik Erlangen, Erlangen, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Not set

ASST Degli Spedali Civili di Brescia, Brescia, Not set

Ospedale San Raffaele, Milano, Not set

Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia, Perugia, Not set

Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Not set

Universita Cattolica del Sacro Cuore, Rome, Not set

IRCCS Istituto Clinico Humanitas, Rozzano, Not set

University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Not set

Tohoku University Hospital, Miyagi, Not set

Osaka University Hospital, Osaka, Not set

Juntendo University Hospital, Tokyo, Not set

Tokyo Metropolitan Komagome Hospital, Tokyo, Not set

Academisch Medisch Centrum, Amsterdam, Not set

University Medical Center Groningen, Groningen, Not set

Leiden University Medical Center, Leiden, Not set

Maastricht Universitair Medisch Centrum, Maastricht, Not set

Universitair Medisch Centrum Utrecht, Utrecht, Not set

Centro Hospitalar Universitario Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon, Not set

Instituto Portugues de Oncologia de Lisboa Francisco Gentil - E.P.E., Lisbon, Not set

Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto, Not set

Institut Catala d'Oncologia, Barcelona, Not set

Hospital Universitari Vall D'Hebron, Barcelona, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Marqués de Valdecilla, Santander, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Hospital Clínico Universitario de Valencia, Valencia, Not set

Addenbrookes Hospital (Cambridge University Hospitals NHS Foundation Trust), Birmingham, Not set

University Hospitals Southampton, Southampton, Not set

Conditions: High-risk Large B-cell Lymphoma (LBCL)

Learn More ›

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

NCT06615479

Recruiting

The purpose of this study is to compare the efficacy and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: Local Institution - 0071, Birmingham, Alabama +123 locations

Local Institution - 0071, Birmingham, Alabama

UCLA Hematology/Oncology - Santa Monica, Los Angeles, California

Local Institution - 0130, Miami, Florida

Winship Cancer Institute, Emory University, Atlanta, Georgia

Local Institution - 0218, Shreveport, Louisiana

Local Institution - 0196, Boston, Massachusetts

Local Institution - 0067, Charlotte, North Carolina

Local Institution - 0216, Winston-Salem, North Carolina

Local Institution - 0193, Cleveland, Ohio

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Local Institution - 0044, Salt Lake City, Utah

Local Institution - 0195, Milwaukee, Wisconsin

Hospital Italiano de Buenos Aires, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0214, ABB, Ciudad Autónoma De Buenos Aires

Hospital Aleman, Buenos Aires, Ciudad Autónoma De Buenos Aires

Royal Prince Alfred Hospital, Camperdown, New South Wales

Local Institution - 0190, Liverpool, New South Wales

Local Institution - 0140, Brisbane, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Monash Health, Clayton, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Local Institution - 0191, Melbourne, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich

Hanusch-Krankenhaus, Vienna, Not set

Local Institution - 0220, Edegem, Antwerpen

Local Institution - 0217, Brussels, Bruxelles-Capitale, Région De

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne, Yvoir, Namur

UZ Gent, Gent, Oost-Vlaanderen

Local Institution - 0012, Nova Lima, Minas Gerais

Local Institution - 0103, São Paulo, SAO Paulo

Local Institution - 0013, Sao Paulo, São Paulo

Local Institution - 0031, São Paulo, Not set

Local Institution - 0069, Calgary, Alberta

Vancouver General Hospital, Vancouver, British Columbia

QEII Health Sciences Centre - Victoria General Site, Halifax, Nova Scotia

Local Institution - 0192, Hamilton, Ontario

CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal, Quebec

Fakultní nemocnice Brno Bohunice, Brno, Brno-město

Local Institution - 0093, Hradec Kralove, Hradec Králové

Vseobecna fakultni nemocnice v Praze, Praha 2, Not set

Rigshospitalet, Copenhagen, Hovedstaden

Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland

Local Institution - 0208, Roskilde, Sjælland

Odense Universitetshospital, Odense, Syddanmark

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa

Hopital Claude Huriez - CHU de Lille, Lille, Nord

Local Institution - 0194, Nantes, Pays-de-la-Loire

Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône

Henri Mondor Hospital, Creteil, Val-de-Marne

Local Institution - 0210, Paris, Not set

TUM Universitätsklinikum, Technische Universität München, Munich, Bayern

Medizinische Hochschule Hannover, Hannover, Niedersachsen

Local Institution - 0211, Magdeburg, Sachsen-Anhalt

Local Institution - 0204, Chemnitz, Sachsen

Universitätsklinikum Leipzig, Leipzig, Sachsen

Local Institution - 0212, Kiel, Schleswig-Holstein

Local Institution - 0213, Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set

Universitaetsklinikum Heidelberg, Heidelberg, Not set

Klinikum Nuernberg Nord, Nuremberg, Not set

Universitaetsklinikum Wuerzburg, Wuerzburg, Not set

University Hospital of Patras, Patras, Achaḯa

Evangelismos General Hospital of Athens, Athens, Attikí

Local Institution - 0115, Chaidari, Attikí

Local Institution - 0125, Budapest, Not set

Sheba Medical Center, Ramat Gan, HaMerkaz

Sourasky Medical Center, Tel Aviv, Tell Abīb

Hadassah Medical Center, Jerusalem, Yerushalayim

Local Institution - 0107, Milan, Lombardia

Istituto Clinico Humanitas, Rozzano, Milano

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Piemonte

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0119, Genova, Not set

Local Institution - 0106, Udine, Not set

Nagoya City University Hospital, Nagoya, Aichi

Local Institution - 0105, Kashiwa, Chiba

Hyogo Medical University Hospital, Nishinomiya, Hyogo

Kanazawa University Hospital, Kanazawa, Ishikawa

Kyushu University Hospital, Fukuoka, Not set

Kumamoto University Hospital, Kumamoto, Not set

National Hospital Organization Okayama Medical Center, Okayama, Not set

Osaka Red Cross Hospital, Osaka, Not set

Japanese Red Cross Medical Center, Tokyo, Not set

Yamagata University Hospital, Yamagata, Not set

Local Institution - 0147, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0146, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0148, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0149, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0176, Nijmegen, Gelderland

Maastricht UMC+, Maastricht, Limburg

Local Institution - 0179, Amsterdam, Noord-Holland

Universitair Medisch Centrum Utrecht, Utrecht, Not set

Oslo Universitetssykehus Ullevål, Oslo, Not set

Centrum Onkologii Ziemi Lubelskiej, Lublin, Lubelskie

Uniwersyteckie Centrum Kliniczne, Gdańsk, Pomorskie

Local Institution - 0084, Katowice, Not set

Local Institution - 0183, Łódź, Łódzkie

Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set

Fundeni Clinical Institute, Bucuresti, București

Institutul Regional de Oncologie, Iași, Not set

Local Institution - 0178, Riyadh, Not set

Local Institution - 0180, Singapore, Central Singapore

Local Institution - 0181, Singapore, Central Singapore

CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]

Local Institution - 0203, Palma, Balears [Baleares]

Local Institution - 0201, Badalona, Barcelona [Barcelona]

Clinica Universidad de Navarra, Pamplona, Navarra

Local Institution - 0202, Granada, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Local Institution - 0023, Lund, Skåne Län [se-12]

Karolinska Universitetssjukhuset Huddinge, Huddinge, Not set

Inselspital Bern, Bern, Berne

Cantonal Hospital St.Gallen, st.Gallen, Sankt Gallen

Local Institution - 0150, Taipei City, Taipei

Local Institution - 0151, Taichung, Not set

Local Institution - 0152, Taipei, Not set

Local Institution - 0200, Taipei, Not set

Local Institution - 0170, Ankara, Not set

Addenbrooke's Hospital, Cambridge, Cambridgeshire

Local Institution - 0155, London, London, City Of

Local Institution - 0157, Oxford, Oxfordshire

The Christie NHS Foundation Trust, Manchester, Not set

Freeman Hospital, Newcastle upon Tyne, Not set

Conditions: Relapsed or Refractory Multiple Myeloma (RRMM)

Learn More ›

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

NCT04245839

Recruiting

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/r FL or MZL. The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This study is divided into three periods: * Pretreatment, which consists of screening assessme... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: UCLA Medical Centre-Santa Monica, Santa Monica, California +58 locations

UCLA Medical Centre-Santa Monica, Santa Monica, California

University Of Colorado Cancer Center, Aurora, Colorado

Yale Cancer Center, New Haven, Connecticut

Local Institution - 0601, Hollywood, Florida

Washington University School Of Medicine, Miami, Florida

Northwestern University, Chicago, Illinois

Local Institution - 109, Niles, Illinois

University Of Iowa, Iowa City, Iowa

Cancer Center of Kansas, Wichita, Kansas

University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Massachusetts General Hospital - Dana-Farber Cancer Institute, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Karmanos Cancer Center, Detroit, Michigan

Local Institution - 118, Detroit, Michigan

Atlantic Health System Morristown Medical Center, Morristown, New Jersey

Memorial Sloan Kettering Cancer Center, New York, New York

Novant Health Presbyterian Medical Center, Charlotte, North Carolina

Local Institution - 120, Fargo, North Dakota

Cleveland Clinic Foundation, Cleveland, Ohio

Providence Cancer Center/Earle A. Chiles Res. Inst., Portland, Oregon

University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Local Institution - 126, Pittsburgh, Pennsylvania

Local Institution - 113, Sioux Falls, South Dakota

Local Institution - 125, Knoxville, Tennessee

Texas Oncology, Dallas, Texas

Houston Methodist Hospital, Houston, Texas

The University of Texas - MD Anderson Cancer Center, Houston, Texas

University Of Virginia Health System, Charlottesville, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

Allgemeinen Krankenhaus (AKH) Wien - Medizinische Universitaet Wien, Wien, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

Hopital Maisonneuve - Rosemont, Montreal, Quebec

CHRU-Hopital Claude Huriez, Lille, Not set

CHU Montpellier - Hôpital Saint Eloi, Montpellier CEDEX 5, Not set

Hopital Saint Louis, Paris Cedex 10, Not set

Centre Hospitalier Lyon-Sud, Pierre-Benite CEDEX, Not set

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 02, Not set

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse, Not set

Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg

Universitätsklinikum Regensburg, Regensburg, Bayern

Local Institution - 506, Berlin, Not set

Local Institution - 503, Karlsruhe, Not set

Local Institution - 505, Kiel, Not set

University Hospital Cologne, Köln, Not set

LMU Klinikum der Universitat Munchen, Munich, Not set

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo, Not set

Local Institution - 302, Bologna, Not set

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples, Not set

Local Institution - 553, Sapporo-shi, Hokkaido

Local Institution - 550, Chuo-ku, Tokyo

Local Institution - 551, Minato-ku, Tokyo

Local Institution - 552, Fukuoka, Not set

Local Institution - 352, Barcelona, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Virgen Del Rocio, Sevilla, Not set

Karolinska Hospital, Stockholm, Not set

University College London Hospitals NHS Foundation Trust - University College Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Lymphoma, Non-Hodgkin

Learn More ›

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Recruiting

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS) or Refractory Myasthenia Gravis (MG).

Gender:

ALL

Ages:

Between 18 years and 60 years

Trial Updated:

08/19/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +34 locations

University of Alabama at Birmingham, Birmingham, Alabama

University of California, Irvine, Irvine, California

University of Colorado Anschutz Medical Campus, Aurora, Colorado

Colorado Blood Cancer Institute, Denver, Colorado

Yale-New Haven Hospital, New Haven, Connecticut

University of Kansas Medical Center, Kansas City, Kansas

Local Institution - 0039, New Orleans, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Washington University School of Medicine, Saint Louis, Missouri

Hackensack University Medical Center, Hackensack, New Jersey

Icahn School of Medicine at Mount Sinai, New York, New York

Neurological Institute of New York, New York, New York

University of Cincinnati Medical Center, Cincinnati, Ohio

Cleveland Clinic Mellen Center, Cleveland, Ohio

Local Institution - 0037, Portland, Oregon

Swedish Medical Center, Seattle, Washington

Medical College of Wisconsin, Milwaukee, Wisconsin

Antwerp University Hospital, Edegem, Antwerpen

UZ Gent, Gent, Oost-Vlaanderen

Hopital Claude Huriez - CHU de Lille, Lille, Nord

Pitie Salpetriere University Hospital, Paris, Ville De Paris

Universitaetsklinikum Essen, Essen, Nordrhein-Westfalen

Universitaetsklinikum Duesseldorf, Düsseldorf, Not set

Universitaetsklinikum Erlangen, Erlangen, Not set

Klinikum der Universität München Großhadern, München, Not set

Local Institution - 0008, Milano, Lombardia

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Local Institution - 0016, Barcelona, Barcelona [Barcelona]

Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña]

Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De

Hospital Universitari i Politecnic La Fe, València, Not set

Manchester Royal Infirmary, Manchester, Lancashire

University College London Hospital, London, London, City Of

Salford Royal Hospital, Salford, Manchester

Barts Health NHS Trust, London, Not set

Conditions: Multiple Sclerosis, Myasthenia Gravis

Learn More ›

A Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

Recruiting

The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.

Gender:

ALL

Ages:

16 years and above

Trial Updated:

08/14/2025

Locations: Local Institution - 0009, Birmingham, Alabama +70 locations

Local Institution - 0009, Birmingham, Alabama

Local Institution - 0038, Los Angeles, California

Local Institution - 0051, Los Angeles, California

Local Institution - 0035, Palo Alto, California

University of Colorado Anschutz Medical Campus, Aurora, Colorado

Mayo Clinic in Florida, Jacksonville, Florida

Local Institution - 0002, Miami, Florida

Local Institution - 0008, Tampa, Florida

Local Institution - 0036, Tampa, Florida

Local Institution - 0062, Zephyrhills, Florida

Local Institution - 0052, Boston, Massachusetts

Local Institution - 0011, Rochester, Minnesota

Atlantic Health System Overlook Medical Center, Summit, New Jersey

Local Institution - 0040, New York, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Local Institution - 0005, New York, New York

Local Institution - 0039, New York, New York

Local Institution - 0010, Chapel Hill, North Carolina

Local Institution - 0065, Charlotte, North Carolina

Local Institution - 0012, Cincinnati, Ohio

Local Institution - 0003, Cleveland, Ohio

Local Institution - 0041, Oklahoma City, Oklahoma

Baylor Scott and White Research Institute, Dallas, Texas

Local Institution - 0007, Seattle, Washington

Local Institution - 0016, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0017, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0023, Buenos Aires, Ciudad Autónoma De Buenos Aires

Local Institution - 0037, Vienna, Wien

Local Institution - 0031, Salzburg, Not set

Local Institution - 0020, Leuven, Vlaams-Brabant

Local Institution - 0058, Sao Paulo, São Paulo

Local Institution - 0021, São Paulo, Not set

Local Institution - 0022, São Paulo, Not set

Local Institution - 0048, Vancouver, British Columbia

Local Institution - 0045, Toronto, Ontario

Local Institution - 0056, Odense, Syddanmark

Local Institution - 0047, Copenhagen, Not set

Local Institution - 0018, Montpellier, Hérault

Local Institution - 0019, Rennes, Not set

Local Institution - 0064, Paris, Île-de-France

Local Institution - 0029, Köln, Nordrhein-Westfalen

Local Institution - 0030, Magdeburg, Sachsen-Anhalt

Local Institution - 0028, Leipzig, Sachsen

Local Institution - 0026, Berlin, Not set

Local Institution - 0027, Erlangen, Not set

Local Institution - 0043, Ramat Gan, HaMerkaz

Local Institution - 0042, Jerusalem, Not set

Local Institution - 0025, Roma, Lazio

Local Institution - 0032, Milan, Milano

Local Institution - 0044, Rome, Roma

Local Institution - 0070, Pisa, Toscana

Local Institution - 0055, Sapporo, Hokkaido

Local Institution - 0072, Yokohama, Kanagawa

Local Institution - 0068, Bunkyo-ku, Tokyo

Local Institution - 0069, Shinjuku-ku, Tokyo

Local Institution - 0067, Chiba, Not set

Local Institution - 0054, Fukuoka, Not set

Local Institution - 0063, Okayama, Not set

Local Institution - 0053, Osaka, Not set

Local Institution - 0046, Amsterdam, Noord-Holland

Local Institution - 0034, Łódź, Łódzkie

Local Institution - 0024, Bytom, Śląskie

Local Institution - 0049, Gliwice, Śląskie

Local Institution - 0013, Lisbon, Lisboa

Local Institution - 0015, Barcelona, Barcelona [Barcelona]

Local Institution - 0071, Esplugues de Llobregat, Barcelona [Barcelona]

Local Institution - 0014, Málaga, Not set

Local Institution - 0060, London, London, City Of

Local Institution - 0061, London, London, City Of

Local Institution - 0050, London, London, City Of

Local Institution - 0057, London, London, City Of

Conditions: Lupus Erythematosus, Systemic, Lupus Nephritis

Learn More ›

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

NCT06413498

Recruiting

The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/14/2025

Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +96 locations

Banner MD Anderson Cancer Center, Gilbert, Arizona

USC/Norris Comprehensive Cancer Center, Los Angeles, California

University of California, Davis Comprehensive Cancer Center, Sacramento, California

UC San Diego Moores Cancer Center, San Diego, California

University of California San Francisco Medical Center, San Francisco, California

UCLA Department of Medicine-Hematology/Oncology, Santa Monica, California

Stanford Cancer Institute, Stanford, California

Colorado Blood Cancer Institute, Denver, Colorado

Moffitt Cancer Center, Tampa, Florida

Winship Cancer Institute, Atlanta, Georgia

IU Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana

Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Boston Medical Center, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Corewell Health - Lemmen-Holton Cancer Pavilion, Grand Rapids, Michigan

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York

Novant Health Cancer Institute Hematology, Charlotte, North Carolina

Novant Health Cancer Institute Hematology- Forsyth, Winston-Salem, North Carolina

University of Cincinnati Medical Center, Cincinnati, Ohio

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio

Oregon Health and Science University, Portland, Oregon

University of Tennessee Medical Center, Knoxville, Tennessee

Baptist Cancer Center, Memphis, Tennessee

Henry-Joyce Cancer Clinic, Nashville, Tennessee

St. David's South Austin Medical Center, Austin, Texas

Houston Methodist Hospital Cancer Center, Houston, Texas

The University of Texas MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

LDS Hospital, Salt Lake City, Utah

Swedish Cancer Institute, Seattle, Washington

University of Washington Medical Center, Seattle, Washington

Royal Prince Alfred Hospital, Camperdown, New South Wales

Royal North Shore Hospital, St. Leonards, New South Wales

Royal Adelaide Hospital, Adelaide, South Australia

Epworth HealthCare, Richmond, Victoria

Sir Charles Gairdner Hospital, Nedlands, Western Australia

Ordensklinikum Linz GmbH Elisabethinen, Hamatologie mit Stammzelltransplantation, Hamostaseologie und medizinische Onkologie, Linz, Not set

Paracelsus Medizinischen Privatuniversitaet, Salzburg, Not set

University Hospital St. Poelten, Department of Internal Medicine I, St. Poelten, Not set

Medical University of Vienna, Wien, Not set

Cliniques Universitaires Saint-Luc, Brussels, Not set

University Hospital of Antwerp, Edegem, Not set

UZ Leuven, Flemish Brabant, Not set

UZ Gent, Gent Oost-Vlaanderen, Not set

QEII Health Sciences Centre, Halifax, Not set

University Health Network - The Princess Margaret Cancer Centre, Toronto, Not set

CHU de Lille- Hopital Claude Huriez, Lille, Not set

Institut Paoli Calmettes, Marseille, Not set

CHU De Montpellier - Hopital Saint Eloi, Montpellier, Not set

Centre Hospitalier Universitaire de Nantes, Nantes, Not set

Hopital Saint Louis, Paris, Not set

Hopital Saint Antoine, Paris, Not set

Hôpital Lyon Sud, Pierre-Benite, Not set

Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set

CHU de Rennes, Rennes, Not set

CHU de Toulouse. IUCT Oncopole, Toulouse, Not set

Universitatsklinikum Hamburg Eppendorf, Hamburg, Not set

Universitatsklinikum Koln, Klinik I fOr lnnere Medizin, Köln, Not set

Universitatsklinikum Leipzig, Leipzig, Not set

TUM Klinikum, Rechts der Isar, Klinik und Poliklinik fur Innere Medizin III, Hamatologie und Onkologie, München, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, MI

IRCCS AOU di Bologna, Bologna, Not set

Ospedale San Raffaele, Milano, Not set

AOU Città della Salute e della Scienza Presidio Ospedaliero Molinette, Torino, Not set

Hyogo Medical University Hospital, Hyogo, Not set

Nagoya City University Hospital, Nagoya City, Not set

The University of Osaka Hospital, Osaka, Not set

Hamamatsu University Hospital, Shizuoka, Not set

Jichi Medical University Hospital, Tochigi, Not set

Juntendo University School of Medicine Juntendo Clinic, Tokyo, Not set

Japanese Red Cross Medical Center, Tokyo, Not set

Amsterdam UMC - Location vUmc, Amsterdam, Not set

University Medical Center Groningen, Groningen, Not set

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Wroclaw, Not set

ICO Badalona-H.U. Germans Trias i Pujol, Badalona, Not set

Hospital Clínic de Barcelona, Barcelona, Not set

Hospital Duran i Reynals, Barcelona, Not set

Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar, Not set

Hospital Universitario Ramon Y Cajal, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Clinica Universidad de Navarra, Pamplona, Not set

Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Marqués de Valdecilla, Santander, Not set

Hospital Universitario Virgen del Rocio, Seville, Not set

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Not set

Inselspital - Universitätsspital Bern, Berne, Not set

Centre Hospitalier Universitaire Vaudois, Lausanne, Not set

University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology Centre, Bristol, Not set

University Hospital of Wales, Cardiff, Not set

Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, Not set

King's College Hospital, London, Not set

University College London Hospital, London, Not set

Newcastle Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

NCT05250973

Active Not Recruiting

The purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone (D-VCd) treatment regimens (Arm A: daratumumab + immediate VCd treatment and Arm B: daratumumab + deferred VCd) in newly diagnosed systemic amyloid light chain (AL) amyloidosis with cardiac involvement and to identify potential mitigation strategies for cardiac toxicity (cohort 1); to characterize the pharmacokinetics of subcutaneous (SC) daratumumab, among racial and ethni... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/14/2025

Locations: City of Hope, Duarte, California +45 locations

City of Hope, Duarte, California

Smilow Cancer Hospital/Yale Cancer Center, New Haven, Connecticut

Moffitt Cancer Center, Tampa, Florida

Winship Cancer Institute Emory University, Atlanta, Georgia

Tufts Medical Center, Boston, Massachusetts

Boston University Medical Center, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Memorial Sloan Kettering, New York, New York

Levine Cancer Institute, Charlotte, North Carolina

Wake Forest University - Baptist Medical Center, Winston-Salem, North Carolina

University Hospital of Cleveland, Cleveland, Ohio

Ohio Health Research Institute, Columbus, Ohio

West Penn Hospital, Pittsburgh, Pennsylvania

UT Southwestern Medical Center, Dallas, Texas

VCU Medical Center, Richmond, Virginia

University of Washington, Seattle, Washington

Tom Baker Cancer Center, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

University Health Network UHN Princess Margaret Cancer Centre, Toronto, Ontario

Peking University First Hospital, Beijing, Not set

Peking University People s Hospital, Beijing, Not set

West China Hospital Si Chuan University, Chengdu, Not set

First affiliated Hospital of Zhejiang University, Hangzhou, Not set

Ruijin Hospital Shanghai Jiao Tong University, Shanghai, Not set

CHU de Limoges, Limoges Cedex, Not set

Centre hospitalier Lyon-Sud, Pierre Benite cedex, Not set

CHU De Poitiers, Poitiers, Not set

CHU Rangueil, Toulouse, Not set

Charite Campus Benjamin Franklin, Berlin, Not set

Universitatsklinikum Essen, Essen, Not set

Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg, Not set

Alexandra General Hospital of Athens, Athens, Not set

Università Degli Studi Di Napoli Federico Ii, Napoli, Not set

Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma, Not set

University Medical Center Groningen, Groningen, Not set

Hospital Maastricht University Medical Center, Maastricht, Not set

UMC Utrecht, Utrecht, Not set

Hosp. Univ. Germans Trias I Pujol, Badalona, Not set

Hosp Univ Vall D Hebron, Barcelona, Not set

Hosp Clinic de Barcelona, Barcelona, Not set

Clinica Univ. de Navarra, Madrid, Not set

Clinica Univ. de Navarra, Pamplona, Not set

Hosp Clinico Univ de Salamanca, Salamanca, Not set

Leicester Royal Infirmary - Haematology, Leicester, Not set

University College Hospital, London, Not set

Conditions: Amyloidosis

Learn More ›

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

NCT06564038

Recruiting

The purpose of this study is to assess the safety and efficacy of AZD0486 administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/08/2025

Locations: Research Site, Boston, Massachusetts +53 locations

Research Site, Boston, Massachusetts

Research Site, New Brunswick, New Jersey

Research Site, New York, New York

Research Site, Charlotte, North Carolina

Research Site, Columbus, Ohio

Research Site, Portland, Oregon

Research Site, Philadelphia, Pennsylvania

Research Site, Providence, Rhode Island

Research Site, Houston, Texas

Research Site, Heidelberg, Not set

Research Site, Melbourne, Not set

Research Site, Nedlands, Not set

Research Site, Beijing, Not set

Research Site, Guangzhou, Not set

Research Site, Jinan, Not set

Research Site, Tianjin, Not set

Research Site, Zhengzhou, Not set

Research Site, Ostrava - Poruba, Not set

Research Site, Praha 2 - Nové Město, Not set

Research Site, Praha, Not set

Research Site, Aalborg, Not set

Research Site, Aarhus N, Not set

Research Site, Copenhagen, Not set

Research Site, Odense C, Not set

Research Site, Montpellier, Not set

Research Site, Paris, Not set

Research Site, Saint Cloud, Not set

Research Site, Villejuif Cedex, Not set

Research Site, Kiel, Not set

Research Site, Köln, Not set

Research Site, München, Not set

Research Site, Würzburg, Not set

Research Site, Koto-ku, Not set

Research Site, Matsuyama-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Busan, Not set

Research Site, Seoul, Not set

Research Site, Barcelona, Not set

Research Site, Madrid, Not set

Research Site, Palma de Mallorca, Not set

Research Site, Santiago de Compostela, Not set

Research Site, Valencia, Not set

Research Site, Changhua, Not set

Research Site, Kaohsiung, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Derriford, Not set

Research Site, London, Not set

Research Site, Oxford, Not set

Conditions: Chronic Lymphocytic Leukaemia, Small Lymphocytic Leukaemia, Mantle-cell Lymphoma, Large B-cell Lymphoma, B-cell Non-Hodgkin Lymphoma

Learn More ›

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

NCT04569032

Active Not Recruiting

This clinical trial will study brentuximab vedotin with CHP to find out if the drugs work for people who have certain types of peripheral T-cell lymphoma (PTCL). It will also find out what side effects occur when brentuximab vedotin and CHP are used together. A side effect is anything the drugs do besides treating cancer. CHP is a type of chemotherapy that uses three drugs (cyclophosphamide, doxorubicin, and prednisone). CHP is approved by the FDA to treat certain types of PTCL.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +68 locations

University of Alabama at Birmingham, Birmingham, Alabama

Stanford Cancer Center, Stanford, California

Stanford Hospital and Clinics, Investigational Drug Services, Stanford, California

Rocky Mountain Cancer centers, LLP, Aurora, Colorado

Rocky Mountain Cancer centers, LLP, Boulder, Colorado

Rocky Mountain Cancer centers, LLP, Colorado Springs, Colorado

Rocky Mountain Cancer centers, LLP, Denver, Colorado

Rocky Mountain Cancer centers, LLP, Lakewood, Colorado

Rocky Mountain Cancer centers, LLP, Littleton, Colorado

Rocky Mountain Cancer centers, LLP, Lone Tree, Colorado

Rocky Mountain Cancer centers, LLP, Longmont, Colorado

Rocky Mountain Cancer centers, LLP, Pueblo, Colorado

Rocky Mountain Cancer centers, LLP, Thornton, Colorado

Tulane Cancer Center, New Orleans, Louisiana

Tulane Medical Center, New Orleans, Louisiana

Memorial Sloan Kettering Cancer Center David H. Koch Center for Cancer Care, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Oncology_Hematology Care Clincal Trials,LLC, Cincinnati, Ohio

Cleveland Clinic taussig Cancer Center Investigational Pharmacy, Cleveland, Ohio

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

Cleveland Clinic, The, Cleveland, Ohio

Oncology_Hematology Care Clincal Trials,LLC, Fairfield, Ohio

VCU at Stony Point, Richmond, Pennsylvania

Texas Oncology-Austin Midtown, Austin, Texas

Texas Oncology-Austin Central, Austin, Texas

The University of Texas MD Anderson Cancer Center, Houston, Texas

US Oncology Investigational Products Center (IPC), Irving, Texas

US Oncology Investigational Products Center(IPC), Irving, Texas

US Oncology lnvestigational Products Center (IPC), Irving, Texas

Texas Oncology-Northeast Texas, Longview, Texas

Texas Oncology-Northeast Texas, Palestine, Texas

Texas Oncology-Northeast Texas, Paris, Texas

Texas Oncology-Northeast Texas, Tyler, Texas

Virginia Oncology Associates, Chesapeake, Virginia

Virginia Oncology Associates, Hampton, Virginia

Virginia Oncology Associates, Newport News, Virginia

Virginia Oncology Associates, Norfolk, Virginia

VCU Health-Adult Outpatient Pavilion(AOP)Investigational Drug Services(Active as of 5/3/2022), Richmond, Virginia

VCU Massey Cancer Center-Radiation Oncology, Richmond, Virginia

VCU Medical Center -InPatient, Richmond, Virginia

VCU Medical Center Critical Care Hospital, Richmond, Virginia

Virginia Commonwealth University, Richmond, Virginia

Massey Cancer Center Clinical & Translational Research Lab, Richmond, Virginia

Virginia Oncology Associates, Virginia Beach, Virginia

CHU Grenoble Alpes, Tranche, Rhone-alpes

Hopital Emile Muller, Mulhouse Cedex, Not set

Höpital Haut Levéque - CHU Bordeaux Service d'hématologie clinique et thérapie cellulaire, Pessac Cedex, Not set

Azienda Ospedaliero Universitaria di Bologna - IRCCS, Bologna, Emilia-romagna

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Lombardia

Fondazione Irccs San Matteo, Pavia, Lombardy

IRCCS Ospedale Policlinico San Martino, Genova, Other

Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS Candiolo - Oncologia Medica, Candiolo, Turin

Azienda Ospedaliera Universitaria Integrata Verona Policlinico G.B. Rossi, Verona, Not set

IEC Trials, Hospital La Milagrosa., Madrid, Other

Hospital Universitario De La Paz, Madrid, Other

Cetir Centre Medic, Barcelona, Not set

Hospital Duran I Reynals - Institut Catala d'Oncologia, Barcelona, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Clinico Universitario de Salamanca, Salamanca, Not set

Oxford University Hospitals, Headington, Other

UCLH Hospitals, London, Not set

Hammersmith Hospital, London, Not set

MACMILLIAN Cancer Centre, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Peripheral T-cell Lymphoma

Learn More ›

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

NCT06191744

Recruiting

Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with previously untreated FL. Adverse events and change in disease condition will be assessed. Epcoritamab is an investigat... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/04/2025

Locations: Scripps Mercy Hospital /ID# 265393, San Diego, California +244 locations

Scripps Mercy Hospital /ID# 265393, San Diego, California

Sansum Clinic Research /ID# 261596, Santa Barbara, California

Rocky Mountain Cancer Centers - Boulder /ID# 261203, Boulder, Colorado

Christiana Care Health Service /ID# 261207, Newark, Delaware

Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 262445, Jacksonville, Florida

Advent Health /ID# 261578, Orlando, Florida

Orlando Health Cancer Institute /ID# 260983, Orlando, Florida

Beacon Cancer Care /ID# 260670, Coeur d'Alene, Idaho

Northwestern University- Robert H. Lurie Comprehensive Cancer Center /ID# 259814, Chicago, Illinois

Cancer Care Specialists Of Central Illinois /ID# 272464, Decatur, Illinois

Illinois Cancer Care, PC /ID# 261526, Peoria, Illinois

Fort Wayne Medical Oncology and Hematology- South Office /ID# 259583, Fort Wayne, Indiana

University of Iowa Health Care /ID# 262132, Des Moines, Iowa

University of Louisville Hospital /ID# 260544, Louisville, Kentucky

Norton Cancer Institute - St. Matthews /ID# 261076, Louisville, Kentucky

New England Cancer Specialists - Westbrook /ID# 260672, Westbrook, Maine

University of Maryland, Baltimore /ID# 259538, Baltimore, Maryland

Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 259476, Bethesda, Maryland

St. Luke's Hospital - Chesterfield /ID# 260489, Chesterfield, Missouri

Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 260006, Billings, Montana

Nebraska Cancer Specialists (NCS) - Regional Cancer Center - St Francis Location /ID# 262506, Grand Island, Nebraska

NHO - Nebraska Hematology-Oncology /ID# 269692, Lincoln, Nebraska

Nebraska Cancer Specialists - Omaha - Wright Street /ID# 262505, Omaha, Nebraska

University of Nebraska Medical Center /ID# 261996, Omaha, Nebraska

University of New Mexico /ID# 261083, Albuquerque, New Mexico

Presbyterian Kaseman Hospital /ID# 262451, Albuquerque, New Mexico

Presbyterian Rust Medical Center /ID# 262447, Rio Rancho, New Mexico

New York Oncology Hematology - Albany Cancer Center /ID# 261814, Albany, New York

NYU Langone Hospital - Long Island /ID# 265531, Mineola, New York

NYU Langone Medical Center /ID# 264518, New York, New York

Icahn School of Medicine at Mount Sinai /ID# 259595, New York, New York

New York Oncology Hematology /ID# 270208, Troy, New York

Clinical Research Alliance, Inc. /ID# 261078, Westbury, New York

Novant Health Presbyterian Medical Center /ID# 259740, Charlotte, North Carolina

Novant Health Forsyth Medical Center /ID# 259741, Winston-Salem, North Carolina

Oncology Hematology Care, Inc - Blue Ash /ID# 261204, Cincinnati, Ohio

Taylor Cancer Research Center /ID# 260488, Maumee, Ohio

Oncology Associates of Oregon, P.C. /ID# 261816, Eugene, Oregon

MUSC Hollings Cancer Center /ID# 259604, Charleston, South Carolina

Prisma Health /ID# 259602, Greenville, South Carolina

Texas Oncology - Austin Midtown /ID# 261208, Austin, Texas

Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 261206, Dallas, Texas

MD Anderson Cancer Center /ID# 260984, Houston, Texas

Oncology Consultants /ID# 268390, Houston, Texas

Joe Arrington Cancer Research /ID# 260382, Lubbock, Texas

Intermountain Healthcare LDS Hospital /ID# 259759, Salt Lake City, Utah

Virginia Cancer Specialists - Fairfax /ID# 261205, Fairfax, Virginia

Oncology and Hematology Associates of Southwest Virginia /ID# 261592, Roanoke, Virginia

Swedish Cancer Institute - Edmonds /ID# 266356, Edmonds, Washington

Swedish Cancer Institute - Issaquah /ID# 266358, Issaquah, Washington

Vista Oncology - East Olympia /ID# 261360, Olympia, Washington

Virginia Mason Hospital & Medical Center /ID# 260549, Seattle, Washington

Swedish Cancer Institute /ID# 260370, Seattle, Washington

Northwest Medical Specialties - Tacoma /ID# 262133, Tacoma, Washington

Royal Prince Alfred Hospital /ID# 259320, Camperdown, New South Wales

Liverpool Hospital /ID# 259321, Liverpool, New South Wales

Peter MacCallum Cancer Center /ID# 260431, Melbourne, New South Wales

Westmead Hospital /ID# 261465, Westmead, New South Wales

Townsville University Hospital /ID# 259323, Douglas, Queensland

Royal Brisbane and Women's Hospital /ID# 259326, Herston, Queensland

Princess Alexandra Hospital /ID# 259329, Woolloongabba, Queensland

Peninsula Private Hospital /ID# 259325, Frankston, Victoria

Fiona Stanley Hospital /ID# 259324, Murdoch, Western Australia

Royal Perth Hospital /ID# 259319, Perth, Western Australia

Algemeen Ziekenhuis klina /ID# 260324, Brasschaat, Antwerpen

Uza /Id# 260319, Edegem, Antwerpen

Cliniques Universitaires UCL Saint-Luc /ID# 260311, Bruxelles, Bruxelles-Capitale

Groupe Sante CHC - Clinique du MontLegia /ID# 260325, Liège, Liege

UZ Gent /ID# 260312, Gent, Oost-Vlaanderen

Universitair Ziekenhuis Leuven /ID# 260304, Leuven, Vlaams-Brabant

AZ-Delta /ID# 260313, Roeselare, West-Vlaanderen

UMHAT Dr Georgi Stranski EAD /ID# 260763, Pleven, Not set

Acibadem City Clinic Tokuda University Hospital EAD /ID# 260685, Sofia, Not set

UMHAT Sveti Ivan Rilski /ID# 259277, Sofia, Not set

SHAT Hematologic Diseases /ID# 260457, Sofia, Not set

Victoria Hospital /ID# 260770, London, Ontario

The Ottawa Hospital - General Campus /ID# 264470, Ottawa, Ontario

CSSS Alphonse-Desjardins, CHAU de Levis /ID# 260527, Levis, Quebec

Disc_Royal Victoria Hospital / McGill University Health Centre /ID# 261075, Montreal, Quebec

Centre Hospitalier de l'Université de Montréal (CHUM) /ID# 260617, Montréal, Quebec

Peking University First Hospital /ID# 259816, Beijing, Beijing

Peking University Third Hospital /ID# 259806, Beijing, Beijing

The First Affiliated Hospital of Xiamen University /ID# 260014, Xiamen, Fujian

Sun Yat-Sen University Cancer Center /ID# 260478, Guangzhou, Guangdong

Guangdong Provincial People's Hospital /ID# 260446, Guangzhou, Guangdong

Zhujiang Hospital of Southern Medical University /ID# 260558, Guangzhou, Guangdong

Nanfang Hospital of Southern Medical University /ID# 260795, Guangzhou, Guangdong

Shenzhen People's Hospital /ID# 260137, Shenzhen, Guangdong

Affiliated Cancer Hospital of Guangxi Medical University /ID# 260537, Nanning, Guangxi

People's Hospital of Henan Province /ID# 259619, Zhengzhou, Henan

Henan Cancer Hospital /ID# 259618, Zhengzhou, Henan

Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 259743, Wuhan, Hubei

Hubei Cancer Hospital /ID# 260506, Wuhan, Hubei

Hunan Cancer Hospital /ID# 260439, Changsha, Hunan

The First Affiliated Hospital of Soochow University /ID# 260507, Suzhou, Jiangsu

The First Affiliated Hospital of Nanchang University /ID# 260556, Nanchang, Jiangxi

Jiangxi Provincial Cancer Hospital /ID# 260559, Nanchang, Jiangxi

The First Hospital of China Medical University /ID# 260217, Shenyang, Liaoning

Shandong Cancer Hospital /ID# 260808, Jinan, Shandong

Fudan University Cancer Hospital /ID# 260564, Shanghai, Shanghai

West China Hospital, Sichuan University /ID# 260015, Chengdu, Sichuan

Tianjin Cancer Hospital /ID# 259807, Tianjin, Tianjin

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 259616, Tianjin, Tianjin

The Affiliated Cancer Hospital of Xinjiang Medical University /ID# 260644, Urumqi, Xinjiang

Yunnan Cancer Hospital /ID# 260645, Kunming, Yunnan

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 259744, Hangzhou, Zhejiang

Zhejiang Cancer hospital /ID# 259742, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University /ID# 260566, Wenzhou, Zhejiang

Clinical Hospital Dubrava /ID# 260452, Zagreb, Grad Zagreb

Klinicka bolnica Merkur /ID# 260393, Zagreb, Grad Zagreb

Klinicki bolnicki centar Sestre milosrdnice /ID# 260456, Zagreb, Grad Zagreb

Klinicki bolnicki centar Zagreb /ID# 260364, Zagreb, Grad Zagreb

Klinicki bolnicki centar Rijeka /ID# 260455, Rijeka, Primorsko-goranska Zupanija

Klinicki Bolnicki Centar (KBC) Split /ID# 260454, Split, Splitsko-dalmatinska Zupanija

Zadar General Hospital /ID# 260837, Zadar, Not set

Fakultní nemocnice Hradec Králové - Sokolská /ID# 260560, Hradec Králové, Hradec Kralove

Fakultni nemocnice Kralovske Vinohrady /ID# 260572, Praha, Not set

Regionshospitalet Godstrup /ID# 260778, Herning, Midtjylland

Roskilde Sygehus /ID# 260780, Roskilde, Sjælland

Odense University Hospital /ID# 260777, Odense, Syddanmark

Sygehus Lillebalt, Vejle /ID# 260781, Vejle, Syddanmark

CHU de CAEN - Hopital de la Cote de Nacre /ID# 260875, Caen, Calvados

CHU Brest - Hôpital de la Cavale Blanche /ID# 260601, Brest, Finistere

Hopital Prive d'Antony /ID# 260598, Antony, Ile-de-France

Hopital Prive du Confluent /ID# 260596, Nantes CEDEX 2, Loire-Atlantique

Centre Hospitalier D'Avignon /ID# 260511, Avignon, Provence-Alpes-Cote-d Azur

HCL - Hopital Lyon Sud /ID# 260508, Pierre Benite CEDEX, Rhone

Centre Hospitalier du Mans /ID# 260510, Le Mans CEDEX 9, Sarthe

CH Libourne - Hopital Robert Boulin /ID# 261478, Libourne, Not set

Hôpital Saint-Louis /ID# 260509, Paris, Not set

Clinique Sainte-Anne /ID# 261528, Strasbourg, Not set

Staedtisches Klinikum Karlsruhe /ID# 260348, Karlsruhe, Baden-Wuerttemberg

Universitaetsklinikum Frankfurt /ID# 260388, Frankfurt am Main, Hessen

Klinikum Kassel /ID# 260432, Kassel, Hessen

St.-Antonius-Hospital /ID# 260520, Eschweiler, Nordrhein-Westfalen

Klinikum Ludwigshafen /ID# 260688, Ludwigshafen am Rhein, Rheinland-Pfalz

Otto-von-Guericke-Universitaet /ID# 260425, Magdeburg, Sachsen-Anhalt

Olympion General Clinic /ID# 262395, Patras, Achaia

General Hospital of Athens Laiko /ID# 259708, Athens, Attiki

University General Hospital Attikon /ID# 260855, Athens, Attiki

General University Hospital of Alexandroupolis /ID# 260858, Alexandroupolis, Not set

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 259709, Athens, Not set

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 260051, Gyor, Gyor-Moson-Sopron

Tolna Varmegyei Balassa Janos Korhaz /ID# 260048, Szekszard, Tolna

Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 260050, Szombathely, Vas

Orszagos Onkologiai Intezet /ID# 260052, Budapest, Not set

Soroka University Medical Center /ID# 259937, Be'er Sheva, HaDarom

HaEmek Medical Center /ID# 259936, Afula, Haifa

Meir Medical Center /ID# 259938, Kfar Saba, HaMerkaz

The Chaim Sheba Medical Center /ID# 259934, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 259933, Tel Aviv, Tel-Aviv

Hadassah /ID# 259935, Jerusalem, Yerushalayim

Rabin Medical Center /ID# 268328, Petah Tikva, Not set

IRCCS Istituto Clinico Humanitas /ID# 260887, Rozzano, Lombardia

Istituto di Candiolo Fondazione del Piemonte per l'Oncologia IRCCS /ID# 260889, Candiolo, Torino

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 260886, Bologna, Not set

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 260888, Palermo, Not set

AUSL di Reggio Emilia - Arcispedale Santa Maria Nuova /ID# 260744, Reggio Emilia, Not set

Fondazione Policlinico Universitario Campus Bio-Medico /ID# 260891, Roma, Not set

Fujita Health University Hospital /ID# 264679, Toyoake, Aichi

Matsuyama Red Cross Hospital /ID# 266426, Matsuyama-shi, Ehime

University of Fukui Hospital /ID# 265680, Yoshida-gun, Fukui

National Hospital Organization Kyushu Cancer Center /ID# 265960, Fukuoka-shi, Fukuoka

Kyushu University Hospital /ID# 267861, Fukuoka-shi, Fukuoka

Fukushima Medical University Hospital /ID# 264994, Fukushima-shi, Fukushima

Chugoku Central Hospital /ID# 266520, Fukuyama, Hiroshima

Sapporo Medical University Hospital /ID# 265031, Sapporo, Hokkaido

Kobe City Medical Center General Hospital /ID# 266379, Kobe-shi, Hyogo

Hitachi General Hospital /ID# 265676, Hitachi-shi, Ibaraki

Kitasato University Hospital /ID# 264675, Sagamihara-shi, Kanagawa

Kanagawa Cancer Center /ID# 265497, Yokohama-shi, Kanagawa

Okayama University Hospital /ID# 267135, Okayama-shi, Okayama

Kansai Medical University Hirakata Hospital /ID# 266019, Hirakata-shi, Osaka

Kindai University Hospital /ID# 265038, Osaka sayama-shi, Osaka

Tokyo Metropolitan Komagome Hospital /ID# 267692, Bunkyo ku, Tokyo

The University of Tokyo Hospital /ID# 266422, Bunkyo-ku, Tokyo

Yamaguchi University Hospital /ID# 265619, Ube, Yamaguchi

University of Yamanashi Hospital /ID# 264677, Chuo-shi, Yamanashi

Aomori Prefectural Central Hospital /ID# 265692, Aomori, Not set

Chiba Cancer Center /ID# 267316, Chiba, Not set

Seoul National University Bundang Hospital /ID# 260009, Seongnam-si, Gyeonggido

Seoul National University Hospital /ID# 260007, Seoul, Seoul Teugbyeolsi

Asan Medical Center /ID# 260010, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 260008, Seoul, Seoul Teugbyeolsi

Bravis Ziekenhuis /ID# 259055, Bergen op Zoom, Noord-Brabant

Elisabeth Tweesteden Ziekenhuis /ID# 261239, Tilburg, Noord-Brabant

Olvg /Id# 259543, Amsterdam, Noord-Holland

St. Antonius Ziekenhuis /ID# 259053, Nieuwegein, Utrecht

HagaZiekenhuis /ID# 261220, Den Haag, Zuid-Holland

Leids Universitair Medisch Centrum /ID# 259049, Leiden, Zuid-Holland

Franciscus Gasthuis & Vlietland, Locatie Gasthuis /ID# 259052, Rotterdam, Zuid-Holland

Rijnstate /ID# 261219, Arnhem, Not set

Universitair Medisch Centrum Groningen /ID# 259051, Groningen, Not set

Auckland City Hospital /ID# 259330, Grafton, Auckland

North Shore Hospital /ID# 260824, Takapuna, Auckland

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopern /ID# 260633, Lodz, Lodzkie

Pratia MCM Krakow /ID# 260075, Krakow, Malopolskie

Narodowy Instytut Onkologii im. M. Sklodowskiej /ID# 260861, Warszawa, Mazowieckie

Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej /ID# 260170, Kielce, Swietokrzyskie

Fundacao Champalimaud /ID# 259652, Lisbon, Lisboa

Unidade Local de Saude de Gaia/Espinho, EPE /ID# 259655, Vila Nova de Gaia, Porto

Unidade Local de Saude de Santa Maria, EPE /ID# 259650, Lisboa, Not set

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE /ID# 259649, Porto, Not set

Pan American Center for Oncology Trials, LLC /ID# 260265, Rio Piedras, Not set

Auxilio Mutuo Cancer Center /ID# 260262, San Juan, Not set

Fundeni Clinical Institute /ID# 260296, Bucharest, Bucuresti

Institutul Oncologic Prof Dr. Ion Chiricuta Cluj Napoca /ID# 259704, Cluj-Napoca, Cluj

Institutul Regional de Oncologie /ID# 259697, Jassi, Iasi

Spitalul Clinic Coltea /ID# 259699, Bucharest, Not set

Clinical Hospital Center Zvezdara /ID# 260900, Belgrade, Beograd

University Clinical Center Serbia /ID# 259271, Belgrade, Beograd

University Clinical Center Kragujevac /ID# 259274, Kragujevac, Sumadijski Okrug

Institute for Oncology of Vojvodina /ID# 260223, Sremska Kamenica, Vojvodina

University Clinical Center Vojvodina /ID# 259272, Novi Sad, Not set

Narodny onkologicky ustav /ID# 260638, Bratislava, Bratislavsky Kraj

Univerzitna nemocnica Martin /ID# 260631, Martin, Zilinsky Kraj

Alberts Cellular Therapy /ID# 260514, Pretoria, Gauteng

Haemalife Inc. /ID# 260513, Kuilsrivier, Western Cape

Instituto Catalan de Oncologia (ICO) Badalona /ID# 260495, Badalona, Barcelona

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 261439, L'Hospitalet de Llobregat, Barcelona

Hospital Universitario Marques de Valdecilla /ID# 260497, Santander, Cantabria

Clinica Universidad de Navarra - Pamplona /ID# 260496, Pamplona, Navarra

Hospital Universitario Vall d'Hebron /ID# 260490, Barcelona, Not set

Hospital Clinic de Barcelona /ID# 260492, Barcelona, Not set

Hospital Santa Creu i Sant Pau /ID# 260498, Barcelona, Not set

Hospital San Pedro de Alcantara /ID# 260502, Caceres, Not set

CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 261512, Madrid, Not set

MD Anderson Madrid /ID# 260500, Madrid, Not set

Hospital Universitario de Salamanca /ID# 260491, Salamanca, Not set

Sodra Alvsborgs sjukhus /ID# 261168, Boras, Vastra Gotalands Lan

National Taiwan University Hospital /ID# 260341, Taipei City, Taipei

China Medical University Hospital /ID# 260357, Taichung, Not set

Taichung Veterans General Hospital /ID# 260361, Taichung, Not set

National Cheng Kung University Hospital /ID# 260363, Tainan, Not set

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 259804, Istanbul, Not set

Ege Universitesi Tip Fakultesi /ID# 259803, Izmir, Not set

Kocaeli University Med Faculty /ID# 259717, Kocaeli, Not set

Ondokuz Mayis Universitesi /ID# 259713, Samsun, Not set

Istanbul Florence Nightingale Hospital /ID# 271291, Şişli, Not set

Derriford Hospital and the Royal Eye Infirmary /ID# 262671, Plymouth, Devon

Hammersmith Hospital /ID# 261124, London, England

Queen Alexandra Hospital /ID# 269708, Portsmouth, Hampshire

Leeds Teaching Hospitals NHS Trust /ID# 260466, Leeds, West Yorkshire

The Christie Hospital /ID# 260463, Manchester, Not set

The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 260792, Newcastle upon Tyne, Not set

Conditions: Follicular Lymphoma (FL)

Learn More ›